State lawmakers are looking at ways to strengthen Rhode Island’s prescription drug monitoring program. They say there are too many gaps in the current system that allow people to abuse prescription drugs.
California-based Prime Healthcare Services won approval earlier this week to buy Woonsocket’s Landmark Medical Center. But the approval came with conditions. One is that the company keep Rhode Island regulators abreast of a federal investigation it’s under for allegedly over-billing Medicare. Another is that Prime invest in primary care and in preventing hospital re-admissions. The Department of Health expressed some concern about Prime’s practices at other hospitals, but department head Michael Fine said the terms of the deal to acquire Landmark should allay those concerns.
For Rhode Islanders between 15 and 44 years old, the leading cause of death is accidental drug overdose, usually involving prescription painkillers. State health leaders are calling it an epidemic. There’s growing evidence that tracking the number of pills doctors prescribe to potential abusers might ease the problem. But Rhode Island’s fledgling prescription drug monitoring program is just getting started.
Recently, I reported on Rhode Island's fledgling prescription drug monitoring program (listen to that story here). It's a program that's supposed to spot troubling trends in prescription drug misuse. And as you might know, there's plenty of trouble to spot in Rhode Island, where prescription drug overdose death rates have soared along with rates of addiction to narcotic painkillers.